Last reviewed · How we verify
NCT05440435
Application of Mobile DR in the Diagnosis of Bone Trauma in High Cold Environment
trial testing digital radiography (DR) in Bone Injury in 2,000 participants. Status unknown.
1 October 2022
Quick facts
| Lead sponsor | Rongrong Hua |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 2,000 |
| Start date | 1 January 2022 |
| Primary completion | 1 October 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 4 locations across China |
Drugs / interventions tested
- digital radiography (DR)
Conditions studied
- Bone Injury — all drugs for Bone Injury →
- Artificial Intelligence — all drugs for Artificial Intelligence →
Sponsor
Rongrong Hua
Who can join
Adults 18 to 55, any sex, with Bone Injury or Artificial Intelligence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In the high cold environment, mobile digital radiography (DR) is used to collect the imaging of bone injury patients, and the artificial intelligence diagnosis module is used to diagnose the injury. The quality of images obtained by mobile or conventional DR and the consistency between artificial intelligence and pure artificial diagnosis will be analyzed respectively. Finally, the application value of mobile DR loaded with artificial intelligence diagnosis function in high cold environment is determined.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05440435
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bone Injury
Currently open trials in the same condition.
- NCT06249906 — Efficacy of Bioceramic Materials for Bone Defects Repair · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05440435 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rongrong Hua
- Last refreshed: 19 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05440435.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing